Navigation Links
Trovagene, Inc. Announces Closing of $15 Million Registered Direct Offering of Common Stock
Date:7/31/2013

that cover testing for HPV and other infectious diseases, cancer, transplantation, prenatal and genetic testing.

Certain statements in this press release are forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995. These statements may be identified by the use of forward-looking words such as "anticipate," "believe," "forecast," "estimated" and "intend," among others. These forward-looking statements are based on Trovagene's current expectations and actual results could differ materially. There are a number of factors that could cause actual events to differ materially from those indicated by such forward-looking statements. These factors include, but are not limited to, substantial competition; our ability to continue as a going concern; our need for additional financing; uncertainties of patent protection and litigation; uncertainties of government or fourth party payer reimbursement; limited sales and marketing efforts and dependence upon fourth parties; and risks related to failure to obtain FDA clearances or approvals and noncompliance with FDA regulations. As with any medical diagnostic tests under development, there are significant risks in the development, regulatory approval and commercialization of new products. There are no guarantees that future clinical trials discussed in this press release will be completed or successful or that any product will receive regulatory approval for any indication or prove to be commercially successful. Trovagene does not undertake an obligation to update or revise any forward-looking statement.  Investors should read the risk factors set forth in Trovagene's Form 10-K for the year ended December 31, 2012 and other periodic reports filed with the Securities and Exchange Commission.ContactTrovagene, Inc.FinancialInvestor RelationsStephen Zaniboni

Chief Financial OfficerAmy Caterina

Investor RelationsTrovagene, Inc.Trovagene, Inc.858-952-7594858-952-7593

SOURCE Trovagene, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Trovagene, Inc., Announces Fourth Quarter and Year End 2012 Earnings
2. Trovagene, Inc., Announces Third Quarter and Year to Date Earnings, Provides Milestone Update
3. Trovagene, Inc. Announces Second Quarter and Year to Date Earnings, Provides Milestone Update
4. Trovagene, Inc., Announces Issuance of U.S. Patent for NPM Mutants to Diagnose and Monitor Acute Myeloid Leukemia
5. Keith McCormick Joins Trovagene, Inc. as Head of Commercial Operations
6. CryoLife Announces First European Implant Of HeRO Graft
7. North South Holdings Inc. Announces its First Settlement and License Agreement.
8. Naurex Announces Issuance Of New Patent For Novel Antidepressant GLYX-13
9. BioDrain Announces Medical Advisory Board Comprised of Top Doctors and Healthcare Executive
10. NeuroSigma Announces FDA Approval to Commence Phase III Trial
11. The Galien Foundation Announces 2013 Prix Galien USA Nominees for "Best Biotechnology Product," "Best Pharmaceutical Agent," and "Best Medical Technology"
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... 23, 2015  iMD Companies, Inc. (ICBU) has repositioned itself as ... and grab a foothold in the hydroponic, hemp and medical ... a presence in the sector, and recently partnering with the ... hemp and medical marijuana, iMD is committing to bring its ...
(Date:1/23/2015)... , Jan. 23, 2015   Leatt Corporation  (OTCQB: LEAT), ... equipment for all forms of sports, including extreme motor ... brace, announced today that the UISP Lega Motociclismo Lombardia, ... all riders to wear a neck brace during its ...
(Date:1/23/2015)... , Jan. 23, 2015 Gem Pharmaceuticals announced ... have been enrolled into the Company,s Phase 2 clinical ... safety of Gem,s lead compound, GPX-150 (an investigational medication), ... or metastatic disease. Logo - http://photos.prnewswire.com/prnh/20150123/170966LOGO ...
Breaking Medicine Technology:iMD Companies Poised to Make Impact in Multi-Billion Dollar Medical Marijuana Sector With Recent Investments and Strategic Partnerships 2Leatt Announces Neck Braces Now Required For Motocross/Minicross Racing In Italy 2Leatt Announces Neck Braces Now Required For Motocross/Minicross Racing In Italy 3Gem Pharmaceuticals Announces Enrollment of Initial Patients in its Phase 2 Clinical Trial to Assess the Efficacy and Safety of GPX-150 in Sarcoma Patients 2
... Cardiac Science Corporation (Nasdaq: CSCX ... AED ) and diagnostic cardiac monitoring devices, today announced ... 30, 2009, in line with its previous guidance. The Company ... field product update and a non-cash charge of $44.0 million ...
... Nov. 9 Momentum is building for the early December ... India pharma ingredients, services and technologies event. A combined total of ... countries are expected at the Bombay Exhibition Centre for the ... In addition to high quality exhibitors, the 2009 events include two ...
Cached Medicine Technology:Cardiac Science Announces Third Quarter Results 2Cardiac Science Announces Third Quarter Results 3Cardiac Science Announces Third Quarter Results 4Cardiac Science Announces Third Quarter Results 5Cardiac Science Announces Third Quarter Results 6Cardiac Science Announces Third Quarter Results 7Cardiac Science Announces Third Quarter Results 8Cardiac Science Announces Third Quarter Results 9Cardiac Science Announces Third Quarter Results 10Cardiac Science Announces Third Quarter Results 11Cardiac Science Announces Third Quarter Results 12Cardiac Science Announces Third Quarter Results 13Cardiac Science Announces Third Quarter Results 14Cardiac Science Announces Third Quarter Results 15Cardiac Science Announces Third Quarter Results 16Cardiac Science Announces Third Quarter Results 17Cardiac Science Announces Third Quarter Results 18Cardiac Science Announces Third Quarter Results 19Cardiac Science Announces Third Quarter Results 20Forecast Looks Good for India Pharma Shows 2Forecast Looks Good for India Pharma Shows 3
(Date:1/22/2015)... (PRWEB) January 23, 2015 Angelweddingdress is a ... business invites its customers to follow it on Facebook, Twitter, ... a Valentine’s Day gift. Angelweddingdress draws a lottery every week. ... Sale to Feb. 28, 2015. Click Angelweddingdress homepage ...
(Date:1/22/2015)... Dallas, TX (PRWEB) January 22, 2015 ... the issue of experience and person-centeredness in the long-term ... moving towards action across the continuum. The paper, “The ... the Continuum,” engages perspectives and practices of the patient, ...
(Date:1/22/2015)... (PRWEB) January 22, 2015 Joan Lunden, ... keynote speaker at the upcoming 32nd Annual Miami ... Physicians’ Education Resource®, LLC (PER®) , shares that ... have gone undetected if she had not followed up ...
(Date:1/22/2015)... Four years since the release of their debut recording ... marriage of Avasa & Matthew Love – the duo are pleased ... release through White Swan Records on February 24, 2015. , THE ... path available to all of us to walk out of the ...
(Date:1/22/2015)... (PRWEB) January 22, 2015 Compare-autoinsurance.org has released a ... insured by an auto insurance policy . , Some ... policy. Clients should check the newly released blog post to see ... cars and dangerously damaged vehicles are some of the cars that ...
Breaking Medicine News(10 mins):Health News:Angelweddingdress Invites Its Customers To Follow It On Facebook, Twitter, And Pinterest 2Health News:The Power of Person-Centeredness in Long-Term Care Explored by The Beryl Institute 2Health News:The Power of Person-Centeredness in Long-Term Care Explored by The Beryl Institute 3Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 2Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 3Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 4Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 5Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 6Health News:THE ROAD by Avasa & Matthew Love -- A New Album 2Health News:THE ROAD by Avasa & Matthew Love -- A New Album 3Health News:THE ROAD by Avasa & Matthew Love -- A New Album 4Health News:Some Vehicles Cannot Be Covered By An Auto Insurance Policy! 2
... Patent ... fixation to KFx Medical. , ... San Diego, CA (PRWEB) September 9, 2009 -- KFx Medical Corporation announced today that on ... and Trademark office. The key patent covers a broad range of methods used to perform ...
... , , , , ... converge on the Capitol in scrubs and lab coats this week to bring ... The doctors, all traveling as individuals and at their own expense, ... meet with the doctors of Congress, including Tom Price, MD (GA) and Sen. ...
... Many experience chronic pain that endures for months and ... which may help alleviate symptoms. , , ... , , Registered journalists can ... unrestricted use at http://www.mediaseed.tv . , ...
... NEW YORK, Sept. 9 HMS Holdings Corp. (Nasdaq: HMSY ) today ... , Conference: Morgan Stanley Global Healthcare Conference, ... Location: New York, Presenter: ... ThinkEquity Partners, 6th Annual Growth Conference: G6, Date/Time: ...
... , NEW YORK, Sept. 9 ... Peter G. Peterson Foundation on America,s Affordable Health Choices Act of ... a critical look at longer-term cost implications of a major comprehensive ... making it the first analysis of health care reform costs beyond ...
... 9 Just since midnight, over 50,000 letters have gone ... new campaign to bring attention to the rising numbers of ... National "How Much Longer" Day for Autism ... Department of Education, lawmakers and the Obama Administration asking for ...
Cached Medicine News:Health News:KFx Medical Awarded Key Patent for Knotless Tissue Fixation and Double Row Rotator Cuff Surgery 2Health News:Dr. 'Smith' Comes to Washington: Angry Physicians From All 50 States Rally in DC on Sept. 10 2Health News:Peter G. Peterson Foundation Releases The Lewin Group Study Showing Current House Health Care Reform Proposal Would Lead to Expanded Coverage and Higher Costs 2Health News:Peter G. Peterson Foundation Releases The Lewin Group Study Showing Current House Health Care Reform Proposal Would Lead to Expanded Coverage and Higher Costs 3Health News:Peter G. Peterson Foundation Releases The Lewin Group Study Showing Current House Health Care Reform Proposal Would Lead to Expanded Coverage and Higher Costs 4Health News:With All Eyes On Swine Flu, Thousands of Parents Ask President Obama 'How Much Longer' Until Autism Gets Similar Attention 2Health News:With All Eyes On Swine Flu, Thousands of Parents Ask President Obama 'How Much Longer' Until Autism Gets Similar Attention 3
... to having been designed exclusively for vascular treatments, ... the Smartepil range which ensures fast amortisation of ... systems, it can be fitted with a polarised ... the target to be treated as well as ...
... a KTP laser, very compact and lightweight, ... doubled Nd:YAG) for dermatologic treatments. All the ... LCD Touch-screen. Maximum power is 5 ... 0.7 and 1.0 mm. SmartLite Derm is ...
... is a new and powerful instrument ... light system (MEL @308 nm - ... and vitiligo. Designed to treat recalcitrant ... targeted exposure of extensive lesions without ...
... SmartClinic is a CO2 laser system ... W, ideal for dealing with all therapeutic ... SmartClinic also supplies medium-to-high intensities in super-pulsed ... and delicate surgery. It is also capable ...
Medicine Products: